Advanced malignant solid tumors
Conditions
Interventions
The cohort of diabetes combined with advanced cancer:NA
The cohort of non-diabetes combined with advanced cancer:NA
Sponsors
The 960th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Adult patients >=18 years old; 2. Patients with a a clear histopathological diagnosis of tumor cases; 3.receiving immune checkpoint inhibitor therapy alone or in combination with chemotherapy. 4. The ECOG-PS score is 0-2, and the expected survival is > 2 months; 5. Receiving continuous anti-tumor therapy for >=2 cycles; 6.There is at least one measurable target lesion according to the modified criteria for the evaluation of solid tumor efficacy; 7. The patient's medical records and follow-up information are complete.
Exclusion criteria
Exclusion criteria: 1.pathological diagnosis and disease stage do not meet the inclusion criteria. 2. receiving immunotherapy for no more than 2 cycles; 3. diagnosed with type 1 diabetes or other types of diabetes; 4. primary tumors in other sites; 5. undergoing surgery or other invasive procedures in the past or during immunotherapy; 6. participating in clinical trials. 7. The patient has autoimmune diseases or progressive cardiovascular and digestive diseases..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;No progression free survival; | — |
Countries
China
Contacts
Public ContactGuo Jinmin
The 960th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force
Outcome results
None listed